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ENDOCRINE DISRUPTORS AND RISK ASSESSMENT:
POTENTIAL FOR A BIG MISTAKE
KEITH J. JONES, ESQ.
I. INTRODUCTION
Trillions of dollars could be spent in an attempt to regulate
endocrine disruptors as drinking water pollutants, and it could be a
complete waste of money if the regulations are based on traditional
environmental risk assessment. The federal government is ex-
pected to spend billions of dollars just to develop test methods to
identify chemicals that are endocrine disruptors. Once endocrine
disruptors can be identified and measured in water, traditional en-
vironmental risk assessment would attempt to determine the
amount of harm caused by a specific level of an individual endo-
crine disruptor. This process could also cost billions of dollars.
However, because low levels of one endocrine disruptor may com-
bine with low levels of a different endocrine disruptor that acts in a
similar fashion to cause harm, this approach may not be very effec-
tive. Nevertheless, this method could be the basis for government
regulations requiring drinking water plants to reduce levels of indi-
vidual endocrine disruptors at a staggering cost with little or no
benefit to human health.
In an effort to thoroughly explore the issue stated above, this
Article will review relevant historical and background materials re-
garding endocrine disruptors. It will then explain what endocrine
disruptors are and how they are believed to work. Next, the Article
will look at traditional environmental risk assessment. Following
that, it will describe how water is generally regulated in the United
States. The Article will then specifically describe the federal gov-
ernment's efforts to regulate radon as a drinking water pollutant.
Finally, it will suggest that a similar regulatory approach that relies
upon traditional risk assessment might be inadequate for regulating
endocrine disrupting chemicals as drinking water pollutants be-
cause of their possibly cumulative effects.
II. HISTORY AND BACKGROUND
It is well established that certain chemicals can affect hor-
mones. More than half a century ago, researchers observed that
substances extracted from plants could imitate hormones when in-
(357)
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jected into animals.1 In the 1950s, it was shown that the insecticide
DDT could feminize newborn roosters.2 In her seminal work, Si-
LENT SPRING, Rachel Carson warned against the possibly negative
consequences of society's increasing exposure to a "wide variety of
synthetic estrogens." 3 Nevertheless, in the 1960s, manufactured
hormones that mimicked estrogen and progestin began to be mass
marketed to the public in the form of birth control pills. By the
end of the 1970s, it was determined that certain pesticides were the
probable cause of sterility in men who had worked with them and
that various chemicals could reduce sperm counts. 4
During the 1980s, a growing number of scientists documented
cases of wildlife suffering from an assortment of reproductive, de-
velopmental and behavioral abnormalities.5 No one, however, ap-
peared to be seeing the big picture until 1987, when a grandmother
with a recently-acquired Ph.D. in zoology started gathering hun-
dreds of research papers about the Great Lakes in an effort to
gauge pollution levels only to stumble upon a potentially more per-
vasive problem. 6 Theo Colborn was a pharmacist and a shepherd
before pursuing her doctorate later in life.7 Perhaps it was her
unique background that enabled her to suspect connections re-
lated to hormonal disruption in the seemingly unrelated reports
she reviewed. Regardless, Colborn's work led her to others who
shared her suspicions, and in July 1991, she brought together sev-
eral scientists from varying fields to the Wingspread Conference
Center in Racine, Wisconsin to share and discuss their work related
to hormone disruption.8
Amazingly, the twenty-one participants at the Wingspread Con-
ference, whose specialties ran the gamut from anthropology to zo-
1. See BURNHAM WALKER & JAMES JANNEY, ENDOCRINOLOGY 389-92 (1930)
(demonstrating how hormonal study has gone on for decades).
2. See H. Burlington & V.F. Lindeman, Effect of DDT on Testes and Secondary Sex
Characteristics of White Leghorn Cockerels, Soc'Y FOR EXPERIMENTAL BIOLOGY AND MED.,
48-51 (1950) (naming specific instance of hormones altering animal).
3. See RACHEL CARSON, SILENT SPRING 235-37 (1962) (warning of dangers from
synthetic estrogen exposure).
4. See DEVRA DAVIS, WHEN SMOKE RAN LIKE WATER: TALES OF ENVIRONMENTAL
DECEPTION AND THE BATTLE AGAINST POLLUTION 193-222 (2002) (specifying repro-
ductive damage from endocrine disruptors).
5. See THEO COLBORN ET AL., OUR STOLEN FUTURE: How WE ARE THREATENING
OUR FERTILITY, INTELLIGENCE AND SuRvIvAL-A SCIENTIFIC DETECTIVE STORY 6-10
(1996) [hereinafter COLBORN] (citing numerous studies on detrimental effect of
endocrine disruptors on various species).
6. See id. at 11-12 (explaining accidental discovery of reproductive issues in
animals).
7. See id. at 13 (citing background of woman who brought issues to light).
8. See id. at 170 (highlighting result of Colborn's efforts).
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ology, were able to reach a consensus in just three days. 9 Their
Consensus Statement begins as follows:
We are certain of the following: A large number of man-
made chemicals that have been released into the environ-
ment, as well as a few natural ones, have the potential to
disrupt the endocrine system of animals, including
humans. Among these are the persistent, bioaccumula-
tive, organohalogen compounds that include some pesti-
cides (fungicides, herbicides, and insecticides) and
industrial chemicals, other synthetic products, and some
metals.' 0
The "endocrine disrupting hypothesis," or claim that human
health is threatened by exposure to a multiplicity of chemicals that
interfere with the body's hormone system, was brought to the atten-
tion of the general public in 1996 when Colborn co-authored a
best-selling novel, OUR STOLEN FUTURE . The novel reads like a
detective story and chronicles Colborn's years of piecing together
clues of hormone disruption she found in the reports of other
scientists from divergent fields of study.
Around the same time that Colborn was discovering the world
of hormone disruption, a group of breast cancer activists from New
York City were heavily lobbying the United States Congress to fund
cancer research. 1 They believed that the release of synthetic
chemicals into the environment had resulted in an increase in the
incidence of breast cancer on Long Island, New York. 12 A Long
Island breast cancer study suggested that "estrogen metabolism"
was possibly a vehicle for allowing organochlorine compounds to
cause breast cancer. 13 Consequently, New York Senator Alfonse
D'Amato took the lead in obtaining over one million dollars of
funding for breast cancer research and eventually calling for the
9. See id. (demonstrating clear necessity of solution by clear agreement).
10. See COLBORN, supra note 5, at 260-61 (quoting part of Wingspread Confer-
ence Consensus Statement).
11. See Linda Saslow, Transformed by Passion and Politics, Breast Cancer Movement
Gains Power, N.Y. TIMES, Nov. 8, 1998, at 14LI (introducing another group investi-
gating cancer).
12. See id. (mentioning possible link between hormonal changes and breast
cancer).
13. See Major Study Scrutinizes Environmental Carcinogens, PUBLIC HEALTH MAGA-
ZINE, Winter 1995, Vol. 5, No. 1, available at http://www.cumc.columbia.edu/
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creation of endocrine disruptor screening and testing programs
through federal legislation.1 4
In 1995, the United States Environmental Protection Agency
(EPA) held a series of workshops to develop a plan for assessing the
possible health risks of endocrine disruptors. 15 In May 1996, the
EPA hosted a stakeholder meeting on the issue of endocrine dis-
ruptors, which led the EPA to focus on screening and testing for
endocrine disruptors. 16 Later that same year, in August, the United
States Congress enacted the Food Quality Protection Act (FQPA) 17
and amended the Safe Drinking Water Act (SDWA)1 8 in part to
address endocrine disruptors and the need for more research and
the necessity of developing reliable screening and testing proto-
cols.19 The FQPA obviously focuses on food but also specifically
targets pesticides. 20 The amendments to the SDWA are broader,
and in a section tidled "Estrogenic Substances Screening Program,"
they state the following:
[I]n addition to the substances referred to in the . . .
[FQPA] the Administrator [of EPA] may provide for test-
ing under the screening program authorized by . . .
[FQPA] of any other substance that may be found in
sources of drinking water if the Administrator determines
that a substantial population may be exposed to such sub-
stance. 21
Furthermore, several other federal statutes contain provisions,
which may eventually be used as justification for additional endo-
crine disruptor testing. The Federal Insecticide, Fungicide, and Ro-
denticide Act (FIFRA) 22 gives the EPA authority to require testing
of many pesticides. 23 The federal Food, Drug, and Cosmetics Act
(FDCA)24 also gives the EPA the authority to require testing of
14. See Saslow, supra note 11, at 14LI (explaining how study results led to
funding for research and screening).
15. See Endocrine Disruptor Screening Program, 63 Fed. Reg. 42,852 (Aug.
11, 1998) (citing results of federal investigation into endocrine disruptors).
16. See id. (explaining how report results fostered action).
17. 7 U.S.C. § 136 (1996).
18. 42 U.S.C. § 300j-17 (1994 & Supp. 111 1997).
19. See id. (citing where EPA is given power to screen for contaminants).
20. See Food Quality Protection Act of 1996, 21 U.S.C. § 346(a) (1994 & Supp.
III 1997) (mentioning specific government action in response to EDSTAC).
21. See Safe Drinking Water Act Amendments of 1996, 42 U.S.C. § 300j-17
(1994 & Supp. III 1997) (detailing EPA procedures).
22. 7 U.S.C. § 136(a) (c) (2) (B) (1994).
23. See id. (citing where EPA is given power to require pesticide testing).
24. 21 U.S.C. § 346(a) (1994 & Supp. III 1997).
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other pesticides plus chemicals that may have a cumulative effect
with pesticides. 25 Finally, the federal Toxic Substances Control Act
(TSCA) 26 authorizes the EPA to require testing of hazardous chem-
icals when there are specific exposure-based findings to support
such testing.27 In October 1996, the EPA created a federal advisory
committee to examine the issue of endocrine disruptors in greater
detail than anyone had previously.28 The Endocrine Disruptor
Screening and Testing Advisory Committee (EDSTAC) brought to-
gether representatives from drinking water providers, environmen-
tal groups, the EPA, other federal agencies, state agencies, public
health organizations, different industries, additional stakeholders
and various scientists to share information about endocrine dis-
ruptors. 29 EDSTAC's primary purpose was to advise the EPA with
regard to designing an adequate and reliable screening and testing
program for endocrine disruptors.30 In August 1998, EDSTAC is-
sued its Final Report, which contained a plethora of recommenda-
tions. Notably, Congress had already required the EPA to develop a
screening program for endocrine disruptors by August 1998.3 l As a
result, the EPA's Endocrine Disruptor Screening Program (EDSP)
was published in the Federal Register on August 11, 1998.32 The
EDSP was based on many of the recommendations made in the ED-
STAC Final Report.
In addition to developing a screening program by 1998, Con-
gress also required the EPA to implement such a screening pro-
gram by 1999 and make a progress report to Congress regarding
the program by 2000. 33 Nevertheless, the Natural Resources De-
25. See id. (mentioning where EPA is given power to test for chemicals that
may have cumulative effect).
26. 15 U.S.C. § 2603 (1994).
27. See id. (exploring where EPA gets power to test hazardous chemicals).
28. See Endocrine Disruptor Screening Program, supra note 15, at 1-2 (citing
reason for creation of EDSTAC).
29. See id. (detailing participants in EDSTAC).
30. See id. (stating purpose of EDSTAC).
31. See Food Quality Protection Act of 1996, 21 U.S.C. § 346(a)(1) (1994 &
Supp. III 1997) (detailing general requirements for tolerance or exemption for
pesticide chemical residues).
32. See Endocrine Disruptor Screening Program, supra note 15, at 1-2 (setting
forth screening program to determine which pesticide chemicals and other sub-
stances may have effect in humans similar to effect produced by naturally occur-
ring estrogen or other endocrine effects).
33. See 21 U.S.C. § 346(a) (2) (detailing requirements of chemical residues in
processed food); Safe Drinking Water Act Amendments of 1996, 42 U.S.C. § 30 0j-
18 (1994 & Supp. Il1 1997) (discussing drinking water studies identifying groups
within general population who have adverse health effects from exposure to con-
taminants in drinking water).
2006]
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fense Council (NRDC) ultimately filed an action against the EPA
for failure to implement the EDSP in a timely manner.3 4 The re-
sulting consent decree memorialized a settlement agreement re-
quiring the EPA to use "best efforts" to implement screening of
certain suspected endocrine disruptors by specific dates.3 5 In Au-
gust 2000, the EPA did provide a progress report to Congress ex-
plaining the issue of possible endocrine disruption, describing the
EDSP and the EPA's efforts to implement it.36
In October 2001, the EPA established the Endocrine Disruptor
Method Validation Subcommittee (EDMVS) to oversee future im-
plementation of the EDSP.3 7 In May 2002, the EPA made another
progress report to Congress summarizing the endocrine disruptor
work it had done up to that point and the oversight of the EDMVS,
particularly in the area of developing validation processes for new
endocrine disruptor screening and testing methods.3 8 In Decem-
ber 2002, the EPA published its "Proposed Chemical Selection Ap-
proach for Initial Round of Screening," which is the method the
EPA planned to use to select the first group of chemicals to be sub-
jected to the EDSP.39 In December 2003, the EPA's Office of Re-
34. See Natural Resources Defense Council v. Whitman, 2001 U.S. Dist. LEXIS
18435, **3-4 (N.D. Cal. 2001) (complaining EPA did not adopt proper screening
programs required by FQPA and failed to validate tests used in endocrine disrup-
tor screening program by arbitrarily subjecting tests that did not use laboratory
animals to more rigorous validation process than tests involving animals).
35. See id. at *10 (proposing settlement with three components: (1) consent
decree binding EPA to time table for promulgating pesticide regulations; (2) vol-
untary dismissal of cause of action regarding endocrine-disruptor screening pro-
gram and petition for review in Ninth Circuit; (3) entering private settlement
agreement to make best efforts to implement endocrine-disruptor screening pro-
gram that had been proposed by advisory committee formed by EPA, EDSTAC).
NRDC objected to the settlement because it would harm its interests. See id.
36. See U.S. ENVIRONMENTAL PROTECTION AGENCY, ENDOCRINE DISRUPTOR
SCREENING PROGRAM REPORT TO CONGRESS (Aug. 2000) (setting forth pertinent is-
sues concerning endocrine disruptors including overview of endocrine disruptor
issue, screening program, implementation process of endocrine disruptor re-
search, alternative test method development, findings and recommendations for
further testing and action).
37. See Endocrine Disruptor Method Validation Subcommittee, 66 Fed. Reg.
51,951, 51,151 (Oct. 11, 2001) (providing technical advice on Tier 1 Screening
and Tier 2 Testing methods for EPA's EDSP).
38. See U.S. ENVIRONMENTAL PROTECTION AGENCY, REPORT TO U.S. HOUSE OF
REPRESENTATIVES COMMITTEE ON APPROPRIATIONS ON THE STATUS OF THE ENDO-
CRINE DISRUPTOR METHODS VALIDATION SUBCOMMITTEE (May 2002) (giving back-
ground and status of Endocrine Disruptor Methods Validation Subcommittee
meetings and progress). It reported that upcoming meetings would discuss two
tier screening process of laboratory methods performed with various animal assays.
See id.
39. See Endocrine Disruptor Screening Program, Proposed Chemical Selec-
tion Approach for Initial Round of Screening; Request Comment, 67 Fed. Reg.
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search and Development (ORD) issued a multi-year plan outlining
its proposed course of action regarding endocrine disruptors
through 2012.40 The ORD's long-term objectives are to achieve a
better understanding of endocrine disruptors, determine their im-
pact on the environment, including humans, and support the
EPA's screening and testing work.41
Toward the end of 2004, endocrine disruption became a popu-
lar story in the news. In October, the DENVER POST reported a story
about a biologist who suspected the deformed fish he was finding in
the South Platter River resulted from endocrine disruptors being
discharged from a wastewater treatment plant upstream.42 In No-
vember, the PHILADELPHIA INQUIRER published a piece about birth
control hormones and other possible endocrine disrupting chemi-
cals being detected in drinking water.43 In December, the Associ-
ated Press released an article suggesting endocrine disruptors were
causing male fish in the Potomac River near Sharpsburg, Maryland
to grow eggs.44 As a result of such growing media coverage, it is
79,611 (Dec. 30, 2002) (selecting group of chemicals to be screened in Agency's
EDSP but anticipating modification of chemical selection approach for Tier 1
screening lists after examining results of chemical tests, feasibility of incorporating
different categories of chemicals and additional pathways to exposure, and availa-
bility of new priority-setting tools). The EPA developed the EDSP "to determine
whether certain substances may have an effect in humans that is similar to an effect
produced by a naturally occurring estrogen, or such other effects as EPA may des-
ignate." See id. at 79,613. The statute requires the EPA to "provide for the testing
of all pesticide chemicals" and gives the EPA discretionary authority to "provide for
the testing of any other substance that may have an effect that is cumulative to an
effect of a pesticide chemical if the Administrator determines that a substantial
population may be exposed to such a substance." See id. The EPA also has discre-
tionary authority to test "any other substances that may be found in sources of
drinking water if the Administrator determines that a substantial population may
be exposed to such substance." See id. at 79,614.
40. See OFFICE OF RESEARCH AND DEVELOPMENT, U.S. ENVIRONMENTAL PROTEC-
TION AGENCY MULTI-YEAR PLAN (FY2000-2012) FOR ENDOCRINE DISRUPTORS (Dec.
2003) [hereinafter MULTI-YEAR PLAN] (identifying research already performed and
future research needed in order to satisfy three specific long-term goals).
41. See id. at 10-13 (detailing research highlights corresponding to long-term
goals).
42. See Theo Stein & Miles Moffeit, Mutant Fish Prompt Concern: Study Focuses on
Sewage Plant, DENVER POST, Oct. 3, 2004, at A-01 (noting impact of endocrine dis-
rupters on various animals in distinct areas with specific result of heightened fe-
male populations).
43. See Dawn Fallik, Drinking Water Holds Surprises, PHILA. INQUIRER, Nov. 28,
2004, http://www.philly.com/mld/philly/living/health/10287666.htm (discuss-
ing studies performed in New Jersey and Philadelphia that water filtration was not
eliminating chemicals as previously believed).
44. See Male Fish Growing Eggs Found in Potomac, ASSOCIATED PRESS, Dec. 21,
2004 (reporting scientists found male fish growing eggs in Potomac River which
could result from pollutants in water acting as endocrine disruptors).
2006] 363
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likely that the public may soon demand regulation of endocrine
disruptors rather than just screening and testing.
III. WHAT ARE ENDOCRINE DISRUPTING COMPOUNDS?
To understand what endocrine disrupting compounds (EDCs)
are, one must first know a little about the endocrine system. Most
people are probably more familiar with the term "hormone," but it
is synonymous with the term "endocrine" when used with the word
"system." Endocrine simply means secreting internally.45 The pur-
pose of the endocrine system or hormone system is to regulate an
organism's physical processes. 46 For example, the endocrine sys-
tem regulates an organism's growth. 47 The endocrine system has
three basic parts: the glands, the hormones and the receptors. 48
The glands secrete hormones which travel through the blood-
stream in search of the receptors. 49 Receptors are the part of a cell
that binds with the hormone.50 The reaction from this binding re-
sults in the hormone's effect, such as stimulating growth.51 The
hormone to receptor relationship is often described as a key to a
lock relationship. Hormones are keys that travel throughout an or-
ganism's entire body via the blood, but they should only affect cells
that have the proper receptors, or correct locks.52
Every fish, bird and mammal, including humans, has an endo-
crine system. The endocrine glands in the human body are the
hypothalamus, the pituitary gland, the thyroid gland, the adrenal
glands, the pancreas and the gonads.53 The hypothalamus makes
an essential connection between the endocrine system and the ner-
vous system. 54 The pituitary gland is sometimes referred to as the
"master gland" because through its secretions it essentially controls
the thyroid, adrenals and gonads. 55 The thyroid gland modulates
45. See WEBSTER'S NINTH NEW COLLEGIATE DICTIONARY, 410-11 (9th ed. 1983)
(defining endocrine).
46. See GEORGE HEDGE ET AL., CLINICAL ENDOCRINE PHYSIOLOGY 3-5 (1987)
(analyzing endocrine physiology).
47. See id. at 317 (discussing functions of endocrine system).
48. See id. (noting various parts of endocrine system).
49. See id. at 3-5 (noting role of glands within endocrine system).
50. See id. (describing physiological parts and their role in hormonal process).
51. See HEDGE ET AL., supra note 46, at 322 (illustrating process through which
endocrine system affects body function).
52. See id. (noting discussion process through which hormones attach to
receptors).
53. See H. MAURICE GOODMAN, BASIC MEDICAL ENDOCRINOLOGY (Raven Press
1994) (noting parts of human endocrine system).
54. See id. at 29 (discussing role of hypothalamus within endocrine system).
55. See id. at 28 (noting function of pituitary gland).
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the metabolism and affects growth and development.5 6 The ad-
renals or adrenal glands produce hormones in reaction to stress
and influence general cell function. 57 The pancreas produces the
hormone's insulin and glucagon which regulate the levels of glu-
cose or sugar in the blood.58 The gonads produce steroids includ-
ing androgen, estrogen and progestin, which all affect
reproduction, development and growth. 59 Obviously, a well func-
tioning endocrine system is critical for proper development and
maintenance of a human body.
Generally speaking, endocrine disruptors are natural or syn-
thetic chemicals including some pharmaceuticals, pesticides, indus-
trial byproducts and combinations of such substances both natural
and synthetic that have a disruptive effect on an organism's endo-
crine system.60 After much debate, the EDSTAC defined an endo-
crine disruptor as "an exogenous chemical substance or mixture
that alters the structure or function (s) of the endocrine system and
causes adverse effects at the level of the organism, its progeny,
populations, or sub-populations of organisms, based on scientific
principles, data, weight of evidence, and the precautionary princi-
ple." 61 Similarly, the ORD defined endocrine disruptors as "exoge-
nous agents that interfere with the production, release, transport,
metabolism, binding, action, or elimination of the natural hor-
mones in the body responsible for the maintenance of homeostasis
and the regulation of developmental processes." 62 In both of these
definitions, the term "exogenous" simply means from outside the
organism. 63 Some feel the term "endocrine disruptor" is too in-
flammatory and have suggested the more neutral label of hormon-
56. See id. at 46 (describing utility of thyroid gland).
57. See id. at 51 (illustrating role of adrenal glands).
58. See GooDMAN, supra note 53, at 113 (describing role of pancreas as part of
endocrine system).
59. See id. at 249, 271 (noting function of gonads).
60. See RETHA NEWBOLD & WENDYJEFFERSON, Developmental and Reproductive Ab-
normalities Associated with Environmental Estrogens: Diethylstilbestrol (DES) as an Exam-
ple, in ENDOCRINE DISRUPTORS: EFFECTS ON MALE AND FEMALE REPRODUCTIVE
SYSTEMS (CRC Press, 2005) (describing endocrine disruptors and their effect on
endocrine system).
61. See EDSTAC Final Report, 63 Fed. Reg. 154, at 3-4 (Aug. 11, 1998) (codi-
fied at 40 C.F.R. pt. 180) (explaining EDSTAC definition of endocrine disruptor).
62. See MULTI-YEAR PLAN, supra note 40, at 4 (noting OPD definition of endo-
crine disruptor).
63. See WEBSTER'S NINTH NEW COLLEGIATE DICTIONARY 435 (9th ed. 1983) (de-
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ally active agents (HAA).64 Nevertheless, probably partially due to
its neutrality, HAA has not gained widespread acceptance by scien-
tists, nor has the media embraced it.
Regardless of the mechanism's name, disruption of the endo-
crine system can occur in several different ways. Endocrine dis-
ruptors can mimic naturally occurring hormones. For example, the
insecticide DDT is known to cause the same response in cells and
tissues as naturally produced estrogen.65 Exposure to endocrine
disruptors that act like mimics can cause an organism's endocrine
system to over-produce natural hormones that interact with recep-
tors and result in various deviations, such as abnormal growth. 66
Still other endocrine disruptors only inhibit an organism's endo-
crine system and result in the underproduction of necessary hor-
mones, limiting development or reproduction. 67 Finally, other
endocrine disruptors can completely block the instructions from a
hormone to its designated receptor, thereby altogether preventing
normal endocrine function. 68
Just as the forms of endocrine disruption vary, so do the conse-
quences. For years, biologists and ecologists have been docu-
menting the harmful effects of endocrine disruptors on the
reproduction and development of wildlife.69 These effects include,
but are not limited to: "eggshell thinning[;] population declines[;]
impaired viability of offspring[;] altered hormone concentra-
tions[] and changes in sociosexual behavior. ' 70 Many of these ef-
fects have been subsequently duplicated in laboratory experiments
64. See COMMITTEE ON HORMONALLY ACTIVE AGENTS IN THE ENVIRONMENT, NA_
TIONAL RESEARCH COUNCIL, HORMONALLY ACTIVE AGENTS IN THE ENVIRONMENT, 21
(1999) [hereinafter HORMONALLY ACTrVE AGENTS] (explaining contention with
team "endocrine disruptor").
65. See Andrew Rooney & Louis Guillette,Jr., Contaminant Interactions with Ster-
oid Receptors: Evidence of Receptor Binding in ENDOCRINE DISRUPTING CONTAMINANTS:
AN EVOLUTIONARY PERSPECTIVE 82 (Louis Guillette Jr. & D. Andrew Crain eds.,
2000) (setting forth effects of DDT insecticide).
66. See Taisen Iguchi, Embryonic and Neonatal Exposure to Endocrine-Altering Con-
taminants: Effects on Mammalian Female Reproduction in ENDOCRINE DISRUPTING CON-
TAMINANTS: AN EVOLUTIONARY PERSPECTIVE 234 (Louis Guillette Jr. & D. Andrew
Crain eds., 2000) (noting effects when exposed to endocrine disruptors acting like
mimics).
67. See SURESH SIKKA ET AL., ENDOCRINE DISRUPTORS AND MALE INFERTILITY,
ENDOCRINE DISRUPTOR, 292 (1999) (describing consequences of other endocrine
disruptors).
68. See NEWBOLD & JEFFERSON, supra note 60, at 48-49 (explaining how some
endocrine disruptors prevent normal endocrine function).
69. See HORMONALLY ACTIVE AGENTS, supra note 64, at 119 (noting how endo-
crine could effect wildlife).
70. See id. (commenting on specific effects on wildlife).
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with test animals.7 1 It is, however, still unclear whether endocrine
disruptors have the same impact on humans as they do on ani-
mals. 72 Nevertheless, it has been suggested that endocrine dis-
ruptors may cause a number of human ailments and reproductive
disorders, including but not limited to, the following: "in women,
increased cancer rates in the breast, ovary, and uterus ... in men,
increased prostatic and testicular cancer, and poor semen quality
associated with subfertility or infertility .... -73 Given that the endo-
crine system serves the same regulatory purpose in humans as in
animals, it is not difficult to imagine that endocrine disruptors
could produce negative effects in humans similar to those pro-
duced in animals.
Moreover, some fear that the dangers of endocrine disruptors
go well beyond those that may be immediately perceptible. The
"fetal origins of adult disease" theory suggests that prenatal expo-
sure to chemicals including endocrine disruptors may not only
cause defects readily discernible at birth, such as limb malforma-
tions, but may actually be the root of diseases that do not develop
until adulthood.7 4 Devra Davis, noted epidemiologist and advisor
to the World Health Organization, discusses the possibility that sub-
stances like endocrine disruptors may threaten all human life by
eliminating males from the species in her book, WHEN SMOKE RAN
LIKE WATER: TALES OF ENVIRONMENTAL DECEPTION AND THE BATTLE
AGAINST POLLUTION. 7 5 She points to the facts that more men are
having reproductive problems today, fewer boys are being born
than just three decades ago, and among the males born, more and
more are suffering from genital defects such as undescended tes-
tes.7 6 In addition, the relatively low levels of endocrine disruptors
found in the environment may not have an observable effect on a
healthy adult human, but may still pose a tremendous threat to a
fetus developing inside a mother's womb. 77
71. See id. (explaining similar results reached in lab experiments).
72. See id. (noting uncertainty regarding endocrine disruptors effects on hu-
mans versus animals).
73. See NEWBOLD & JEFFERSON, supra note 60, at 48 (describing specific ail-
ments endocrine disruptors cause in humans).
74. See id. at 49-50 (describing "fetal origins of adult disease theory").
75. See DAvIs, supra note 4, at 193 (discussing how endocrine disruptors may
eliminate male species).
76. See id. (noting issues with male species, including increased reproductive
problems).
77. See COLBORN ET AL., supra note 5, at 203-04 (commenting on impact of
endocrine disruptors on fetuses).
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What is disturbing to many people is the seemingly ever-grow-
ing presence of endocrine disruptors in the environment and par-
ticularly in the water. Thanks in part to improvements in detection
methods, endocrine disruptors have been observed in "surface wa-
ters (rivers, lakes and marine waters), groundwater, drinking water
and sewage treatment effluents."78 Residues of antibiotics, hor-
mones, household chemicals, industrial chemicals and numerous
pharmaceuticals can be found in water all over the world.79 These
substances reach the water via a variety of channels including
human consumption and excretion, industrial discharge, and dis-
posal of unused materials through sanitary sewer systems.80 Many
of these materials can pass through wastewater treatment systems
unaffected.81 Another major contributor is stormwater runoff from
confined animal feeding operations (CAFOs), where animals are
administered high doses of growth hormones and antibiotics. 2
Whatever the sources of endocrine disrupting chemicals, their
most dramatic consequence may eventually be found in their po-
tentially synergistic qualities. In the late 1990s, a team of research-
ers at the University of Texas at Austin concluded:
A number of man-made compounds mimic estrogens, al-
though with a lower potency than natural steroidal estro-
gens. When considered individually, these chemicals may
exist in the environment in concentrations too low to be
of concern. In combination, however, low dosages of
these compounds may act synergistically to produce a
strong estrogenic response.8 3
Previously, experiments on turtles involving polychlorinated bi-
phenyls (PCBs) indicated low-dose synergy of endocrine disrupting
78. See Paul Anderson et al., Screening Analysis of Human Pharmaceutical Com-
pounds in US. Surface Waters, 38 ENVTL. SCIENCE TECH. 838 (2004) (explaining
methods in detection that have lead to increased findings of endocrine disruptors
in environment).
79. See id. (listing types of endocrine disruptors found in water).
80. See id. (describing ways endocrine disruptors reach water).
81. See id. (noting how materials can pass through wastewater systems).
82. SeeJanice M. Skadsen et al., The Occurrence and Fate of Pharmaceuticals, Per-
sonal Care Products and Endocrine Disrupting Compounds in a Municipal Water Use Cycle:
A Case Study in the City of Ann Arbor 2, http://www.ci.ann-arbor.mi.us/Public-
Services/Water/WTP/EndocrineDisruptors.pdf (Nov. 2004) (commenting on
how CAFO's storm water runoff contributes to the problem).
83. SeeJudith Bergeron et al., Developmental Synergism of Steroidal Estrogens in Sex
Determination, ENVTL. HEALTH PERSPECTIVES, Vol. 107, No. 2, 1 (Feb. 1999) (describ-
ing effect of combinations of low dosage chemicals).
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chemicals.8 4 Initially, similar synergy was shown for the pesticides
endosulfan and dieldrin; however, the results of these studies could
not be duplicated.8 5 The possible synergistic effect of endocrine
disruptors is still in dispute and will be resolved only through future
scientific research. The potential for several discrete substances to
work together to cause endocrine disruption should not be ig-
nored, especially when efforts are made to assess the risks that en-
docrine disruptors present to human health. A failure to account
for the possible additive effects could result in a completely inaccu-
rate risk assessment.
IV. WHAT IS TRADITIONAL ENVIRONMENTAL RISK ASSESSMENT?
A risk assessment can be performed for any activity or sub-
stance. Every risk assessment requires judgments to be made by the
risk assessor. In numerical terms, risk assessment is the product of
the likelihood of an adverse event and the magnitude of the ensu-
ing harm.8 6 For example, assessing the risk of jumping from the
top of the Empire State Building can be numerically assessed and
then compared to the risk assessment of stepping on a banana peel.
The likelihood of an adverse event is very great for a person who
jumps from the top of the Empire State Building. It could reasona-
bly be stated as 9.9 out of 10. It is not stated as ten out of ten to
allow for a reasonable margin of error. For jumping off the top of
the Empire State Building, the magnitude of the ensuing harm,
which is certain death, could reasonably be stated as ten out of ten.
Therefore, the risk estimate for jumping off the top of the Empire
State Building can be numerically represented as ninety-nine, or
very risky.
By comparison, if a person were to step on a banana peel, the
likelihood of an adverse event is fairly low, despite what cartoons
and comedians would have one believe. The likelihood can reason-
ably be stated as one out of ten. The magnitude of the ensuing
harm from stepping on a banana peel is similarly low. Even assum-
ing it actually causes one to slip and fall, it could reasonably be
stated as three out of ten. Therefore, the risk estimate for stepping
on a banana peel can be numerically represented by three, or not
very risky. The two actions can now be compared. Not surprisingly,
84. See id. (noting experiments with turtles).
85. See id. (finding similar, nonduplicative studies involving pesticides).
86. See Kathy Bunting, Risk Assessment and Environmental Justice: A Critique of the
Current Legal Framework and Suggestions for the Future, 3 BUFF. ENVTL. L.J. 132 (1995)
(noting importance of re-evaluating risk assessment).
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jumping from a tall building is assessed as a much more risk-inten-
sive activity than stepping on the skin stripped from a piece of fruit.
Although this may be a silly example, it does a good job of demon-
strating the fundamentals of risk assessment in a very understanda-
ble way.
More specifically, environmental risk assessment is usually de-
scribed in terms of two components-hazard and exposure. 87 Haz-
ard is a particular substance's toxicity or ability to cause damage to
a living organism. 8  This is generally determined through labora-
tory experiments on animals.89 Sometimes animal data is supple-
mented by information about human experience with the
particular substance.90 In toxicity testing, exposure is the amount
or dose of the particular substance being delivered to the target
organism in order to assess the degree of harm.91 Exposure will
vary depending on the method of delivery.92 Although a substance
may be relatively innocuous on the skin, it may be deadly if ingested
or inhaled. 93
Practically every environmental regulation in the United States
utilizes some type of environmental risk assessment. 94 Every day,
environmental risk assessors perform risk assessments to determine
the risk of harm to the environment and human health that may
result from a particular activity or substance. For example, environ-
mental risk assessors will attempt to determine how much of a par-
ticular pollutant may be discharged into a river before there
becomes a risk of contamination to fish in that river. Since the mid-
1990s, Congress has attempted to include some measure of risk as-
sessment in every new or reauthorized environmental statute.95
The belief among the federal legislature is that environmental risk
87. See MARY O'BRIEN, MAKING BETYER ENVIRONMENTAL DECISIONS: AN ALTER-
NATIVE TO RISK ASSESSMENT 17-25 (2000) (setting forth components of environ-
mental risk assessment).
88. See id. (explaining hazard component).
89. See id. (describing how to determine hazard).
90. See id. (noting combination of human experience with animal studies).
91. See id. (explaining method of determining exposure component of envi-
ronmental risk assessment).
92. See O'Brien, supra note 87, at 17-25 (discussing hazard component).
93. See id. (noting effect of skin exposure versus ingestion or inhalation).
94. See Bunting, supra note 86, at 132 (calling for further examination of link
between risk assessment and environmental justice).
95. See Risk Assessment Improvement Act of 1994, H.R. 4306, 103rd Cong.
(1994). See also Bunting, supra note 86, at 153 (discussing introduction of Risk
Assessment Improvement Act of 1994 as congressional bill that would establish risk
assessment program in EPA).
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assessment will allow regulators to calculate how tax revenue should
be used to protect the most human lives per dollar.96
Congress has charged the EPA with the duty of performing en-
vironmental risk assessments for the federal government. The
EPA's general mission is "to protect human health and to safeguard
the natural environment-air, water, and land-upon which life
depends.'97 To carry out this mission, the EPA's ORD conducts
research in a wide variety of environmental areas in an effort to
reduce risks to human health and the environment based upon the
best available scientific information.98 A major component of the
ORD is the National Center for Environmental Assessment
(NCEA). 99 The NCEA is the primary environmental risk assess-
ment agency in the country.100 The NCEA conducts environmental
risk assessments, develops ways to improve them, and provides gui-
dance to other environmental risk assessors.'01
The NCEA's three major work areas include conducting: (1)
environmental risk assessment; (2) methods research; and (3) envi-
ronmental risk assessment guidance. 10 2 It conducts environmental
risk assessments for substances of national significance such as di-
oxin, mercury and trichloroethylene. 10 3 The NCEA conducts meth-
ods research to improve the "state-of-the-science" of environmental
risk assessment by developing new and scientifically defensible envi-
ronmental risk assessment methods based upon the latest advances
in science and technology. 10 4 Finally, the NCEA provides support
to outside risk assessors through consultations, training, and scien-
tific information such as the dioxin emissions inventory.10 5 Accord-
ing to the NCEA, environmental risk assessment is:
96. See Bunting, supra note 86, at 170 (outlining principles on risk assessment
drawn up by sub-committee of Office of Management and Budget).
97. See U.S. Envtl. Protection Agency: History, http://www.epa.gov/history/
(last visited Apr. 19, 2006) (providing background of EPA).
98. See U.S. Envtl. Protection Agency: Research & Development, http://www.
epa.gov/ord/htm/aboutord/htm (stating how ORD carries out EPA's mission).
99. See U.S. Envtl. Protection Agency: National Center for Environmental As-
sessment, http://cfpubepa.gov/ncea/cfm/aboutncea.cfm?ActType=aboutNCEA
(noting NCEA contribution to ORD).
100. See id. (noting NCEA's primary role).
101. See U.S. Envtl. Protection Agency: Strategic Plan for the Office of Re-
search and Development 62 (May 1996), http://www.epa.gov/osp/strtplan/docu-
ments/ord96strplan.pdf [hereinafter Strategic Plan] (outlining NCEA's modus
operandi).
102. See id. (listing NCEA's three major work areas).
103. See id. (noting chemicals on which NCEA conducts risk assessments).
104. See id. (stating goals of NCEA's methods of research).
105. See id. (noting how NCEA supports outside risk assessors).
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[T]he probability that a harmful consequence will occur
as a result of an action. Risk is a function of hazard and
exposure. For risk to occur, there must be a source of risk
(hazard) and an exposure to the hazard. Risk assessment
is the process by which one attempts to evaluate and pre-
dict the likelihood and extent of harm that may result
from a health or environmental hazard. Risk assessment
provides essential information about the severity and ex-
tent of specific environmental problems for use in EPA
risk management decisions.106
When the EPA performs what it calls "hazardous pollutant risk
assessments," it uses benchmark dose (BMD) methods. 10 7 The
BMD methods work by estimating reference doses (RfDs) and refer-
ence concentrations (RfCs) which are used with other scientific in-
formation to establish standards for non-cancer human health
effects. 108 In the past, RfDs and RfCs were determined on the basis
of no-observed-adverse-effect levels (NOA-ELs).10 9 The NOAELs
are simply the highest dose administered in an animal experiment
where there was no documented adverse health effect. 110 The
BMD methods involve applying mathematical models to dose-re-
sponse data and using the results to formulate benchmark re-
sponses (BMR) such as a certain percentage increase in the
incidence of a particular size and type of tumor as a result of a
certain dose of a particular contaminant."1 '
To facilitate the use of the BMD method, the EPA has devel-
oped Benchmark Dose Software (BMDS). 112 Utilizing the BMDS is
a four-step process. First, a data set is created using the BMDS
spreadsheet capability.'1 3 An existing data set can also be imported
from another source such as a Lotus spreadsheet file.' 1 4 Second,
an appropriate model must be selected based upon the nature of
the data being evaluated through the BMDS."1 5 Third, the run pa-
106. See Strategic Plan, supra note 101, at http://www.epa.gov/osp/strtplan/
documents/ord96strplan.pdf (defining environmental risk assessment).
107. See Benchmark Dose Software, 65 Fed. Reg. 35,925 (June 6, 2000) (stat-
ing particular method used in hazardous pollutant risk assessment).
108. See id. (describing how BMD methods work).
109. See id. (explaining how RfDs and RfCs were determined in past).
110. See id. (defining NOAELs).
111. See id. (explaining how BMD methods work).
112. See Benchmark Dose Software, 65 Fed. Reg. 35,925 (June 6, 2000) (not-
ing software developed to facilitate use of BMD method).
113. See id. (stating step one of utilizing BMDS).
114. See id. (noting another method of getting data sets).
115. See id. (stating second step in utilizing BMDS).
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rameters and run options of the selected model must be speci-
fied.116 Fourth, the selected model is run and textual and graphical
results can then be viewed. 117 The BMDS can be downloaded from
the EPA website, and the EPA encourages professional environmen-
tal risk assessors to use the BMDS and to submit feedback including
criticism of the software." 8
To establish a regulatory scheme, the EPA must first determine
those pollutants that it believes pose the greatest risk of harm to
human health.119 Then, the EPA determines what treatments are
available or could be developed to manage those risks and what the
associated costs would be for a particular treatment strategy.' 20 The
EPA does not, however, make these determinations without assis-
tance. 12 1 The NCEA plays a major role in the EPA's environmental
or ecological risk assessment process. The NCEA performs the ac-
tual risk assessment research to characterize the adverse health ef-
fects that result from exposure to pathogenic or toxic agents. 122
First, the NCEA compiles scientific data regarding human health
and exposure that will be utilized in analytical models. 123 Next, the
NCEA develops analytical models for qualitative and quantitative es-
timates of risks associated with various pollutants. 124 Finally, the
NCEA interprets the output of the analytical models to predict po-
tential risks to human health from various contaminants. 125
Currently, the EPA and the NCEA are working to develop a
comprehensive approach for various chemicals and microbes in
drinking water. The focus is on devising a comparative risk model
to measure risks resulting from exposure to multiple pollutants at
play in a single drinking water source. Exposure to multiple pollu-
tants may result in a variety of health hazards such as gastrointesti-
nal illness, cancer or even reproductive disorders. This kind of
multiple risk analysis is the most difficult to perform, but it is ex-
116. See id. (stating third step in utilizing BMDS).
117. See 65 Fed. Reg. 35,925 (stating fourth step in utilizing BMDS).
118. See id. (noting where one can download BMDS).
119. See Peer Review of EPA Draft Human Health and Ecological Risk Assess-
ment of Perchlorate, 67 Fed. Reg. 75 (Jan. 2, 2002) (stating first step in establish-
ing regulatory schemes); Notice of Public Information Collection Being Reviewed
by the Federal Communications Commission, 67 Fed. Reg. 76 (Jan. 2, 2002).
120. See id. (noting EPA procedures related to establishing regulatory scheme).
121. See id. (noting NCEA role in establishing a regulatory scheme).
122. See id. (stating NCEA procedures).
123. See id. (discussing NCEA's first step regarding data compilation).
124. See Peer Review of EPA Draft Human Health and Ecological Risk Assess-
ment of Perchlorate, 67 Fed. Reg. 75 (noting second step of model development).
125. See id. (noting final NCEA step).
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actly the kind that may be necessary for assessing the human health
risk of endocrine disruptors if it is eventually proved that they have
a synergistic effect in drinking water. As challenging as this task is,
it is not the first time the EPA has encountered it. In fact, the EPA
has developed guidelines for assessing the health risks of chemical
mixtures. 126
V. How Is WATER REGULATED?
The Federal Water Pollution Control Act (FWPCA), 127 more
commonly known as the Clean Water Act (CWA),128 regulates the
discharge of all pollutants into the navigable waters of the United
States. 129 The CWA requires limits be set for discharges of effluent
based upon water quality standards.1 30 Individual states establish
actual water quality standards. 31 Water quality standards must in-
clude the designated use or uses for the waters in question and the
criteria necessary for protecting the designated use or uses.132
When an individual state adopts a water quality standard, the EPA
must review and either approve or disapprove it.133 To assist the
states in creating water quality standards, the EPA publishes nation-
ally recommended water quality criteria based upon the latest avail-
able scientific knowledge.134 These criteria provide the states with
guidance for determining water quality standards, but they are not
regulations themselves.1 35
One of the nationally recommended water quality criteria pub-
lished by the EPA is the Human Health Criteria Calculation Ma-
trix.1 3 6 Human health criteria for water quality are numeric values
126. See Guidelines for the Health Risk Assessment of Chemical Mixtures, 51
Fed. Reg. 34,014 (Sept. 24, 1986) (discussing EPA guidelines).
127. 33 U.S.C. §§ 1251-74 (2000).
128. Clean Water Act, 33 U.S.C. § 1314 (2000).
129. See Water Pollution Control Act, 33 U.S.C. §§ 1251-74 (2000) (noting
discharge regulations).
130. See 33 U.S.C. § 1314(b) (1) (B) (listing factors considered for measures
and practices to be applicable to point sources).
131. See Water Quality Standards General Provisions, 40 C.F.R. pt.
131.4(a) (2006) (noting state responsibility).
132. See id. pt. 131.2 (discussing purpose of water quality standards).
133. See id. pt. 131.5(a) (stating EPA review guidelines).
134. See 33 U.S.C. § 1314(a) (noting development of and publication of
criteria).
135. See id. § 1314(a) (7) (noting guidance to states).
136. See U.S. Envtl. Protection Agency: Human Health Criteria Calculation
Matrix (Nov. 2002), http://www.epa.gov/ost/criteria/hhcalc_matrix.pdf [herein-
after Human Health Criteria Calculation Matrix] (discussing information relating
to calculation of human health criteria).
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for allowing a certain level of a pollutant while still being protective
of human health.'3 7 Criteria are based upon risk assessments de-
rived from toxicity studies on laboratory animals and human data
when available. 138 Currently, some endocrine disruptors such as
PCBs can be found in the Human Health Criteria Calculation Ma-
trix, but they are not in the matrix as a result of endocrine dis-
rupting qualities.1 39 They are there because of their carcinogenic
attributes.140 At the present time, there are no regulations based
upon the CWA that target endocrine disruptors for their endocrine
disrupting properties, but that is not to say they could not be devel-
oped at some point in the future. It is much more likely, however,
that regulation of endocrine disruptors will come as a result of the
SDWA rather than CWA because the SDWA has been amended to
specifically address endocrine disruptors, at least with regard to
screening and testing. 1 4
The SDWA requires the EPA to establish standards for drink-
ing water. 142 Consequently, the EPA creates Maximum Contami-
nant Levels Goals (MCLGs) for drinking water.' 43 Individual
contaminants are evaluated for possible human health effects, and
MCLGs are created with a reasonable margin of safety. 144 These
goals are not legally enforceable and may not even be achievable
with currently available drinking water treatment technology.145
For example, MCLGs are often set at zero. AS a result, the EPA also
creates Maximum Contaminant Levels (MCLs) based upon
MCLGs. 146 When EPA establishes MCLs, it considers costs and en-
sures the levels are actually feasible with currently available drink-
ing water treatment technology. 147 Water that comes out of a tap
must satisfy MCLs. MCLs are legally enforceable standards.1 48
137. See id. (explaining human health criteria).
138. See U.S. Envtl. Protection Agency: National Recommended Water Quality
Criteria (2002), http://www.epa.gov/waterscience/criteria/nrwqc-2002.pdf (not-
ing what criteria are based on). Current and other past National Recommended
Water Quality Criteria can be found at http://www.epa.gov/waterscience/criteria/
wqcriteia.html.
139. See Human Health Criteria Calculation Matrix, supra note 136 (noting
evidence of PCBs).
140. See id. (noting reason for PCBs in Matrix).
141. See 42 U.S.C. § 300j-17 (2000) (noting SDWA screening program).
142. See id. §§ 300f to 300j-26 (setting standards).
143. See id. § 300g-1 (stating goals).
144. See id. (explaining evolution process for contaminants).
145. See id. (stating limitations on goals).
146. See 42 U.S.C. § 300g-1 (2000) (establishing MCL creation).
147. See id. (setting forth process of MCL creation).
148. See id. (noting MCL legal status).
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Both MCLGs and MCLs are based upon human health effects
as determined by various risk assessments.1 49 In conducting such
risk assessments, the EPA is required under the SDWA to use "the
best available, peer-reviewed science and supporting studies con-
ducted in accordance with sound and objective scientific practices;
and data collected by accepted methods or best available methods
.... s150 The SDWA also requires that when the EPA creates a regu-
lation based upon a risk assessment, it must identify the following:
(i) each population addressed by any estimate of public
health effects;
(ii) the expected risk or central estimate of risk for the
specific populations;
(iii) each appropriate upper-bound or lower-bound esti-
mate of risk;
(iv) each significant uncertainty identified in the process
of the assessment of public health effects and studies that
would assist in resolving the uncertainty; and
(v) peer-reviewed studies known to the [EPA] Administra-
tor that support, are directly relevant to, or fail to support
any estimate of public health effects and the methodology
used to reconcile inconsistencies in the scientific data.151
There is no question that if endocrine disrupting compounds are
eventually regulated under the SDWA, such regulation would be
based upon human health effects as determined by risk
assessments.
As with most current federal regulations, the regulation of
drinking water tends to be developed through a process. The EPA
is not yet at the point in the process where it is conducting risk
assessments for endocrine disruptors.152 Presently, the EPA is still
trying to develop screening and testing methods for endocrine dis-
ruptors.'5 3 There are an estimated 87,000 chemicals that should be
149. See id. § S00(g) (b) (3) (A) (stating risk assessment process).
150. See id. (noting which studies and data are to be used).
151. See 42 U.S.C. § 30 0(g) (b) (3) (B) (stating elements of proper regulation
promulgation).
152. See U.S. ENvTL. PROTECTION AGENCY, REPORT TO U.S. HOUSE OF REPRE-
SENTATIVES COMMITTEE ON APPROPRIATIONS ON THE STATUS OF THE ENDOCRINE Dis-
RUPTOR METHODS VALIDATION SUBCOMMITTEE 6 (May 2002) (informing committee
on status of risk assessment process).
153. See id. (noting current position of EPA).
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screened for the potential to cause endocrine disruption.1 54 Based
upon the EDSTAC recommendations, the EPA has focused its ini-
tial screening and testing on compounds that affect estrogen, an-
drogen and thyroid (EAT) hormones because they are important
with regard to reproduction, development and growth in both
humans and wildlife. 15 5
The EPA's basic approach is comprised of three components:
(1) Priority Setting; (2) Tier One Screening; and (3) Tier Two Test-
ing. 156 The EPA's Priority Setting focuses on which potential endo-
crine disruptors have the most potential for exposure to humans. 157
The Tier One Screening will develop screening assays to identify
compounds that have the potential to interact with the EAT hor-
mones.1 58 The Tier Two Testing program has the following three
goals:
(1) Determining whether a substance may cause endo-
crine-mediated effects through or involving estrogen, an-
drogen, or thyroid hormone systems,
(2) Determining the consequences to the organism of the
activities observed in Tier 1, and
(3) Establishing the relationship between doses of an en-
docrine-active substance administered in the test and the
effects observed. 159
Once data have been collected from Tier One Screening and Tier
Two Testing, the EPA will turn its attention to characterizing the
potential risk presented by endocrine disruptors. 160
The EPA intends to perform an "exposure assessment" to char-
acterize human exposure to endocrine disruptors.16 1 The EPA will
also perform a "hazard assessment" for endocrine disruptors by col-
lecting the hazard data resulting from the Tier One Screening and
the Tier Two Testing stages and then comparing it to other relevant
154. See ENDOCRINE DISRUPTOR SCREENING AND TESTING ADVISORY COMMIITEE,
EDSTAC FINAL REPORT, EXECUTIVE SUMMARY, ES-3 (1998) (estimating number of
chemicals recommended for testing).
155. See id. (concluding which compounds should be tested first).
156. See Endocrine Disruptor Screening Program; Proposed Statement of Pol-
icy, 63 Fed. Reg. 71,542 (Dec. 28, 1998) (setting forth EPA testing process).
157. See id. (noting importance of protecting human health).
158. See id. (identifying goals of Tier One screening).
159. See U.S. ENVIRONMENTAL PROTECTION AGENCY, ENDOCRINE DISRUPTOR
SCREENING PROGRAM-EDSP COMPONENTS, http://www.epa.gov/scipoly/oscpendo/
edspoverview/components.htm (last visited Apr. 19, 2006) [hereinafter ENDO-
CRINE DISRUPTOR SCREENING] (stating goals of Tier Two Testing).
160. See id. (explaining EPA characterization process).
161. See id. (identifying exposure assessment process).
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hazard information. 162 Finally, the EPA will conduct the actual
"risk assessment" for endocrine disruptors by integrating the infor-
mation from the exposure assessment and the hazard assess-
ment.1 63 Basically, the EPA will look at the amount of exposure
humans have to endocrine disruptors to determine the potential
for harm from such a level of exposure. It appears that the EPA
only intends to look at the independent effects of individual endo-
crine disruptors or classes of endocrine disruptors rather than un-
dertaking the even more complex task of considering the possibly
interactive (e.g., synergistic) effects of endocrine disruptors.
The EPA's immediate focus with regard to endocrine dis-
ruptors is implementation of the EDSP.164 As a result, the EPA has
assigned staff from its Office of Water, Office of Pesticide Programs,
Office of Pollution Prevention and Toxics, Office of Science Coor-
dination and Policy and Office of General Counsel to participate in
an endocrine disruptors Regulatory Activities Workgroup.165 The
workgroup meets once a week to address issues as they arise from
the implementation of the EDSP. 166 Presently, the workgroup is
focusing on questions surrounding data collection, scope of the
EDSP and sources of drinking water.' 67 This work is complicated
and time intensive. As of February 2004, the workgroup was still
reviewing comments submitted in response to the EDSP notice pub-
lished in the Federal Register in 1998.168
Currently, there is no regulation of endocrine disrupting
chemicals in water in the United States. Although the CWA does
regulate all discharges of pollutants to the navigable waters of the
United States, the first regulation of endocrine disrupting chemi-
cals with regard to water could possibly result from the SDWA. Be-
cause the SDWA already has a provision requiring the EPA to
develop a screening and testing program for endocrine disruptors,
it appears that the initial regulation of endocrine disruptors may be
in drinking water. At present, the EPA is still struggling with the
issues related to the development and implementation of the
162. See id. (creating hazard assessment process).
163. See id. (explaining final risk assessment creation).
164. See ENDOCRINE DISRUPTOR SCREENING, supra note 159 (noting main goals
of EDSP implementation).
165. See id. (listing various participants in EDSP process).
166. See id. (explaining function of EDSP staff).
167. See id. (stating workgroup also analyzes confidential business informa-
tion, cost-sharing provisions, exemptions, statutory authorities and substantial
population).
168. See id. (noting workgroup's continuing efforts to review Federal Register
comments to EDSP).
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screening and testing program for endocrine disruptors. Once
those issues are satisfactorily addressed, the result will be screening
and testing data that will be used for conducting risk assessments.
The results of such risk assessments will be used by policy makers as
the basis for determining how best to regulate endocrine disrupting
compounds. This is the same process that has historically been
used by the EPA to develop regulations for numerous drinking
water pollutants in the past.
VI. How WAS RADON IN DRINKING WATER REGULATED?
Radon is an odorless, colorless and radioactive noble gas. 169
Therefore, a person cannot detect radon with any of the senses.
Radon results from the natural radioactive decay of radium, which
is a byproduct of uranium in the earth's crust. 17° In addition, ra-
don decay forms solid isotopes, which are also undetectable by
human senses and are readily transported when dissolved in
water. 17' Most radon forms from decaying rocks in the top thirty
feet of soil. 172 Underground radon is often carried to the surface
by groundwater where it is released into the air. 17-1 Breathing in
radon is second only to cigarette smoking as a cause of lung cancer
in the United States. 174 Ingestion of radon in drinking water is also
known to cause cancer in other organs including the stomach. 175
Therefore, radon in water poses risks from both ingestion and in-
halation.176 When using water contaminated with radon to shower
or for other household purposes, the radon can be released and
169. See U.S. ENVIRONMENTAL PROTECTION AGENCY, A CITIZEN'S GuIDE TO RA-
DON: THE GuIDE TO PROTECTING YOURSEIF AND YOUR FAMnY FROM RADON, 402-K-
02-66, at 3 (Sept. 2005), http://www.epa.gov/radon/images/citizensguide.pdf
[hereinafter CITIZEN'S GuIDE TO RADON] (explaining characteristics of radon).
170. See id. at 4 (describing formation of radon).
171. SeeJ.R. Garcia-Vindas & M.M. Monnin, Radon Concentration Measurements
in the Presence of Water and its Consequences for Earth Science Studies, 39 RADIATION
MESUREMENTS 3, 319-22 (June 2004) (explaining consequences of solid isotopes,
which are formed by radon decay).
172. See id. (noting typical formation of radon is from decaying rocks).
173. See L. Villalba et al., Radon Concentrations in Ground and Drinking Water in
the State of Chihuaha, Mexico, 80J. ENVTi.. RADIOACTITVrY 2, 139-51 (Dec. 2004) (ex-
plaining high levels of radon attributed to nature of aquifer rocks).
174. See CITIZEN'S GUIDE TO RADON, supra note 169, at 3 (explaining warning
by Surgeon General).
175. See id. at 8 (stating research has shown risk of lung cancer from breath-
ing radon in air is much larger than risk of stomach cancer from swallowing water
with radon in it).
176. See id. (explaining risks of radon in water).
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inhaled. 7 7 Once these risks were medically confirmed, there was a
call for federal regulation of radon in drinking water. 178
The 1986 Amendments to the SDWA required the EPA to set a
standard for radon in drinking water regulating it along with sev-
eral other radionuclides. 179 Due to delays in the creation of these
regulations, the EPA was sued and eventually agreed to promulgate
regulations by 1993. l811 Because radon was known to cause cancer,
its MCLG was set at zero.' 8' After consideration of costs, feasibility
and the need to protect human health, the EPA proposed a radon
MCL of 11,000 becquerel per cubic meter. 18 2 The majority of pub-
lic comment on the proposed MCL was critical of the relatively low
limit and suggested a higher level for radon.1 3 In 1992, Congress
intervened and directed the Office of Technology Assessment to
review the EPA's radon analysis.' 8 4 Around the same time, the Of-
fice of Management and Budget took issue with the EPA's pro-
jected mitigation costs for radon. 8 5 Consequently, in 1994,
Congress ordered the EPA to hold off promulgating a final stan-
dard for radon in drinking water. 186
By way of the 1996 Amendments to the SDWA, Congress re-
quired the EPA to perform a risk assessment for radon as a precur-
sor to new drinking water regulation. 187 The SDWA states in
relevant part:
Prior to proposing a national primary drinking water regu-
lation for radon, the [EPA] Administrator shall arrange
for the National Academy of Sciences to prepare a risk as-
sessment for radon in drinking water using the best availa-
177. See id. (explaining most of risk from radon in water comes from radon
released into air when water is used for showering and other household purposes).
178. See Philip Shabecoff, Measures Offered in Congress on Detection and Cleanup
of Radon, N.Y. TIMES, Mar. 13, 1987, at A15 (stating members of Congress intro-
duced legislation for federal program to help detect and deal with radon).
179. See NAT'i. RFSEARCH COUNCIL, RISK ASSESSMENT OF RAI)ON IN DRINKING
WATe:R, 17 (1999) (noting standards and regulations for radon in drinking water
created by 1986 amendments to SDWA).
180. See id. at 9 (stating EPA was sued over delays in effectuating regulations).
181. See id. (stating MCLG of radon).
182. See id. (explaining factors considered to formulate radon MCL).
183. See id. at 10 (noting criticism of public comment on proposed MCL).
184. See NAT'i. RiSEARCH COUNCIL, supra note 179, at 10 (stating Congress in-
tervened in order to address and assess radon analysis).
185. See id. (noting controversy regarding EPA's projected mitigation costs of
radon).
186. See 42 U.S.C. § 300g-13(B) (i) (2000) (explaining Congress's response to
criticism of handling radon in drinking water).
187. See Safe Drinking Water Act, 42 U.S.C. § 300j-17 (1994 & Supp. 111
1997) (citing where EPA is given power to screen for contaminants).
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ble science .... The risk assessment shall consider each of
the risks associated with exposure to radon from drinking
water and consider studies on the health effects of radon
at levels and under conditions likely to be expected
through residential exposure. 8
The statute also required peer review of the risk assessment for
radon in drinking water. 189 The SDWA gave the EPA thirty months
to prepare a risk assessment for radon in drinking water including a
cost analysis for a potential radon MCL. 19 °1 Once the risk assess-
ment was completed and made available for public comment, the
EPA would have six months to actually propose a MCL for radon.' 9 '
After the proposal of the radon MCL, the EPA would have one year
to promulgate a final radon MCL and related national primary
drinking water regulations.192
The 1996 Amendments to the SDWA also provided for an Al-
ternative Maximum Contaminant Level (AMCL) for radon.193 If it
was determined that the proposed MCL for radon was "more strin-
gent than necessary to reduce the contribution to radon in indoor
air from drinking water to a concentration that is equivalent to the
national average concentration of radon in outdoor air," the EPA
would be required to promulgate an AMCL for radon. 194 In order
to comply with the AMCL, states would need to develop multimedia
radon mitigation programs including "public education, testing,
training, technical assistance, remediation grant and loan or incen-
tive programs, or other regulatory or nonregulatory measures."'1 5
The EPA had to approve a state's multimedia mitigation program,
which would be reviewed every five years to ensure that human
health benefits of complying with the AMCL were equal to or better
than compliance with the MCL.196
188. See 42 U.S.C. § 300g-13(B)(i) (quoting SDWA risk assessment require-
ments).
189. See id. § 300g-13(B) (iii) (noting regulation mandated peer-revision for
risk assessments).
190. See id. § 300g-13(C) (discussing requirements of regulation).
191. See id. § 300g-1 (b) (13) (D) (discussing timeframe of proposed regulation).
192. See id. § 300g-l(b) (13) (E) (describing final radon regulation process).
193. See 42 U.S.C. § 300g-1(b) (13) (F) (explaining maximum contaminant
levels).
194. See id. (discussing alternative maximum contaminant levels).
195. See id. § 300g-1 (b) (13) (G) (ii) (describing elements of multimedia radon
mitigation programs).
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Once the EPA was ready to issue a final MCL and AMCL for
radon, it also was required to promulgate guidance or regulations
"describing the best treatment technologies, treatment techniques,
or other means" for reducing the level of radon in drinking
water. 19 7 In assessing treatment technology, the EPA must consult
with the states and drinking water providers to consider the availa-
bility, costs and effectiveness of the technology both in the labora-
tory and the field.'19 8 The SDWA also required the EPA to consider
the quality of source water when evaluating treatment technol-
ogy. 199 Finally, in completing its evaluation of available treatment
techniques for radon reduction or removal, the EPA had to disclose
any assumptions it made with regard to public health including
human health risk assessments. 2 111
Conducting the human health risk assessment for radon in
drinking water was not an easy task. Data on radon in water varied
greatly across the country2 ° l The Rocky Mountain states, the Appa-
lachian states and the New England states all had public water sup-
plies with elevated levels of radon in comparison to the rest of the
nation. 2112 The amount of radon in water that is released into air is
calculated by the "transfer coefficient," which is estimated by a
mathematical model. 2 -13 The biological effect of radon exposure is
believed to be the result of single alpha particles damaging DNA
and leading to genetic instability as evidenced by tumor growth. 2°14
There are no studies that quantify the cancer risk from ingestion of
water contaminated with radon, so the risk is determined by mathe-
matical models that calculate human tissue's ability to absorb ra-
don. 2°15 A physiologically-based pharmacokinetic (PBPK) model
was developed for radon. 2°16 The PBPK model calculates the behav-
ior of radon in the human body by simulating the ingestion, rate of
197. See id. § 300g-1(b)(15) (describing variance technologies).
198. See 42 U.S.C. § 300g-1(b) (15) (A) (2000) (discussing Administrator's du-
ties when promulgating water regulations).
199. See id. § 300g-l (b) (15) (B) (describing limitations of variance technolo-
gies).
200. See id. § 300g-1 (b) (15) (C) (indicating requirement to disclose assump-
tions in regulations identifying variance technologies).
201. See NAT'L Ri;ESFARCH COUNCIl., supra note 179, at 12 (discussing data on
radon).
202. See id. (pointing out inconsistent radon levels throughout country).
203. See id. (indicating method for predicting radon's rate of release).
204. See id. (discussing genetic effects of radon pursuant to exposure).
205. See id. at 14 (analyzing radon's risks).
206. See NAT'i. RESEARCH COUNCIl, supra note 179, at 14 (identifying model
used to examine radon).
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dissolution into blood, transfer through the bloodstream and ulti-
mate deposition and retention in human tissue. 20 7
A number of mathematical models were used to generate risk
estimates for ingestion and inhalation of radon via drinking
water.208 These models utilized factors such as amount of water in-
gested, duration of exposure and rate of water to air transfer. 20 9
The models relied on numerous assumptions. For example, it was
assumed that "all the radon remained dissolved in the water during
the transfer process" to air.210 The risk estimates for ingestion were
then compared to annual cancer deaths in the United States. 211
The EPA conducted a similar analysis for inhalation, and it was de-
termined that the greatest risk of cancer from radon in drinking
water results from emission into air and subsequent inhalation and
not from direct ingestion.212 The EPA determined that "inhalation
accounts for about 89% of the estimated cancer risk and ingestion
accounts for 11%."213
The EPA fully acknowledged that its risk assessment for radon
in drinking water was based upon an analysis that contained a cer-
tain level of uncertainty. In fact, the related risk assessment docu-
ment produced by the National Academy of Sciences for the EPA
explicitly states:
Estimating potential human exposures to and health ef-
fects of radon in drinking water involves the use of large
amounts of data and the use of models for projecting rela-
tionships outside the range of observed date. The data
and models must be used to characterize population be-
haviors, engineered-system performance, contaminant
transport, human contact, and dose-response relation-
ships among populations in different areas, so large varia-
bility and uncertainties are associated with the resulting
risk characterization. 214
207. See id. (examining method of simulating radon's behavior in human
body).
208. See id. at 15 (discussing models used to obtain risk estimates for radon).
209. See id. at 17-18 (describing factors used in radon models).
210. See id. at 18 (illustrating necessary assumptions models relied upon).
211. See NAT'L RESEARCH COUNCIL, supra note 179, at 16 (analyzing ingestion
risk estimates compared to cancer deaths).
212. See id. (discussing origins of cancer risks from radon).
213. See id. at 17 (breaking down sources into component percentages).
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The reality is that all risk assessments rely to some degree on mod-
els built on assumptions and judgments of risk assessors. The resul-
tant conclusions are estimations at best, but the fact that they are
built on assumptions and judgments does not completely invalidate
the use of risk assessments. The possibility for uncertainty inherent
in the risk assessment process demands the use of the best available
data. For example, because there was data that suggested the real
risk of cancer from radon in drinking water came from inhalation
rather than ingestion, the EPA closely scrutinized and incorporated
those data into the risk assessment. As a result, EPA proposed an
AMCL that allowed for multimedia mitigation rather than just a
traditional regulatory MCL for radon. Similarly, because there are
data suggesting endocrine disrupting compounds may have addi-
tive or synergistic effects, those data should also be fully considered.
Such considerations complicate the regulatory process. Due to the
complications in the risk assessment for radon, the EPA still does
not have a standard for radon in drinking water and is not expected
to have one anytime soon.
VII. WHY WiLL THIs APPROACH FAIL FOR EDCs?
There is no question that there are synthetic chemicals that
mimic naturally occurring hormones and that these chemicals may
produce physiological responses similar to those produced natu-
rally, but there are still a lot of unanswered questions surrounding
endocrine disrupting compounds. One of the biggest questions
about endocrine disruptors is whether they can act synergistically.
While there is a strong body of work showing that certain estrogenic
endocrine disruptors cause reproductive effects in certain species
of fish at environmentally relevant levels, there is relatively little evi-
dence that environmental exposure to endocrine disrupting chemi-
cals can cause adverse effects in humans. Moreover, the
concentration levels of endocrine disruptors in the environment
are simply not well-characterized at the present time.
It would seem that the obvious solution is to test individual
chemicals to see what endocrine effect they have, then test combi-
nations of endocrine disruptors for their effects and, finally, mea-
sure the levels of endocrine disruptors currently in the
environment. At this time, however, scientists are not even certain
which tests would be good indicators of physiological conse-
quences; the EPA currently is struggling to develop test methods.
To some degree, the media, the public and non-governmental orga-
nizations are pushing the EPA to develop tests. Endocrine dis-
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ruptors can be a very volatile subject. Presently, scientists are trying
to generate data sets to show dose-responses between herbicides
and frog deformations, but the public may demand immediate reg-
ulation of endocrine disruptors in drinking water. Any such regula-
tion would need to be based upon risk assessments. The models
needed for such risk assessments have certainly not yet been devel-
oped, especially models that could account for endocrine dis-
ruptors' possibly synergistic effects.
From a regulatory standpoint, endocrine disruptors are an ex-
tremely difficult issue because there are many different sources of
these compounds. For example, personal care products are reach-
ing drinking water sources such as rivers via sewer systems. Ulti-
mately, the only way to regulate some of the synthetic chemicals
may be to eliminate them from commerce, but there is a long way
to go before that decision could be made. The regulation of endo-
crine disruptors in drinking water should probably start with a mon-
itoring program. An agency could collect water samples and
measure concentration levels under different conditions. These
data would then be compared against a known toxicity standard.
Setting a water quality standard for endocrine disruptors, however,
will not be easy because it leads back to the problems with develop-
ing accurate methodologies for screening and testing.
The issue of endocrine disruptors is not going to be resolved
quickly, and it may draw resources away from other areas where
there could be greater impact in terms of protecting water quality.
Programs such as buying open space along water bodies to create
buffer zones, for example, is one area where spending dollars
might be more beneficial. Endocrine disruptors could get in the
way of making significant advancement in other more pressing envi-
ronmental issues for they may not even present a significant health
risk, particularly when compared to other environmental problems.
The human health issues related to endocrine disruptors are
very problematic. To begin, the public has an unrealistic desire to
have "pure water" coming out of the tap. People do not want to be
told that their drinking water has minute traces of estrogen. The
reality, however, is that technology is not to the point that there can
be complete removal of such substances. In fact, the costs of treat-
ment to reach just non-detect levels can be very high for any con-
taminant. Also, the multiple types of endocrine disruptors may
require different treatment technologies to remove them, and each
treatment technology has its own costs. The total costs of removing
every possible endocrine disrupting compound could quickly be-
2006]
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come astronomical. Although the public may want pure water, peo-
ple are not prepared to pay what it would actually cost even if
sufficient technology did exist.
Furthermore, there are many barriers to regulating endocrine
disruptors. By far, the biggest barrier is a cause and effect issue.
The body's endocrine system reacts to chemicals all the time, and it
is very challenging to determine at what point a chemical is causing
a significant and negative change in the endocrine system. It is es-
pecially difficult to link a specific endocrine disruptor to an adverse
impact on the human body because there are so many other possi-
ble factors at play. To date, no definitive link has been established
between human health risks and environmental exposure to endo-
crine disruptors. There are two reasons for the lack of a definitive
link: first, there are few human studies on the effects of endocrine
disruptors, and available epidemiological studies are inconclusive
due to environmental contaminants. Second, it is difficult to extra-
polate from lab animals to human health because many co-occur-
ring endocrine disruptors complicate human and lab animal
studies.
The EPA's Endocrine Disruptor Screening Program is still in a
very early phase. The EPA is trying to establish accurate methods
for measuring concentrations and effects of endocrine disruptors.
The ultimate goal could be for the EPA to set standards for drink-
ing water facilities. However, the irony is that under TSCA and
FIFRA, the federal government is currently allowing these sub-
stances to be used and discharged into the environment. There is
still tremendous uncertainty about the approval process for
pharmaceuticals and chemicals. It is not clear whether the current
screening process for bringing new pharmaceuticals and other
chemicals to market is adequate to address the eventual impact on
the environment or drinking water. Again, there is a lack of cause
and effect evidence. There is a real question as to the proper way
to regulate. It might be more feasible to ban the use of an endo-
crine disruptor or otherwise prevent it from reaching source water
(e.g., source water protection programs) rather than try to remove
it from drinking water.
Another area of growing concern is animals or agriculture as
sources of endocrine disruptors. Farm waste and pet waste could
be an enormous source of endocrine disruptors to water bodies via
urban and suburban storm water runoff. Like so much in the field
of endocrine disruptors, there is just not enough information yet to
make any kind of an informed decision. More information is
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needed to link cause and effect. A great deal more treatment or
removal research is needed, especially to make removal of endo-
crine disruptors feasible, let alone cost effective. Moreover, current
regulation should be made more consistent before new legislation
is passed. The EPA should become a bigger part of the approval
process for new chemicals and pharmaceuticals, rather than being
asked to deal with an approved substance after it has been dis-
charged into the environment.
For the federal government to regulate endocrine disrupting
compounds as drinking water pollutants, it must eventually conduct
risk assessments. If the EPA uses traditional environmental risk as-
sessments for endocrine disruptors, it will be looking at the individ-
ual effects of separate potentially endocrine disrupting compounds.
Relying on the results of such studies, the EPA could develop math-
ematical risk assessment models that would eventually lead to MCLs
for individual endocrine disruptors. However, because there is
some evidence to suggest that certain compounds at low levels act
together to cause endocrine disruption, such MCLs might be inade-
quate because they would still allow various compounds to be dis-
charged into the environment at low levels where they would be
capable of acting in combination with other compounds and still
cause endocrine disruption.
If the issue of regulating endocrine disruptors as drinking
water pollutants based upon traditional environmental risk assess-
ment is not examined now, it is likely that the regulatory process
will continue as usual. The result could be federal regulations that
are devastatingly expensive for drinking water utilities, without sig-
nificant public health benefit, or huge federal spending to create
regulations that could still be challenged by the regulated commu-
nity and ultimately invalidated by the courts. Either way, trillions of
dollars could be spent with little real benefit for water quality or
human health unless the issue is addressed today. The only way to
address this issue is to encourage and support endocrine disruptor
research, especially scientific study of the possibly additive or syner-
gistic effects of potentially endocrine disrupting compounds.
VIII. CONCLUSION
Since the best-selling novel OUR STOLEN FUTURE was published
in 1996, millions of people have become acquainted with the term
"endocrine disruptor." Yet few people are aware that in that same
year the EPA established the EDSTAC to consider how to create a
screening and testing program specifically for endocrine dis-
2006]
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ruptors. Once the EPA has established a screening and testing pro-
gram for endocrine disruptors, it will need to start conducting risk
assessments in order to promulgate drinking water regulation. To-
day, risk assessment plays a central role in all environmental regula-
tion. Most people would agree that there is a need for government
regulations to protect human health from environmental pollu-
tants. It may be premature, however, to focus on endocrine dis-
ruptors as such environmental pollutants.
It is simply too early to speculate on the actual human health
effects of endocrine disruptors, let alone regulate them as drinking
water pollutants, because there are more questions than answers at
this time. Additionally, relying on traditional environmental risk
assessment as the basis of such regulation could be unduly cosly.
Traditional environmental risk assessment with its single pollutant
approach is probably inadequate for addressing the potentially in-
teractive effects of endocrine disrupting compounds at low levels.
If this issue is ignored and drinking water utilities are subjected to
stricter regulations, such regulation could be challenged and ulti-
mately invalidated in court. Although some scientists are looking at
the consequences of regulating endocrine disruptors as water pollu-
tants based upon traditional environmental risk assessment, more
need to be. If not, eventually, some lawyers definitely will.
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